Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

How does sharewise work?


Sign up for free

Get yourself a free user account

Show more

Look for a stock/index

Choose a specific stock or index

Show more


Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard

Show more


Help us make sharewise better and help us in making it a success

Show more
sharewise ist auf Deutsch und Englisch verfügbar.
sharewise is available in German and English.

Top Buy/Sell

Security Price Target price
Alibaba Group Holding Ltd ADR €216.50 €215.00 Inc. €2,683.5 €2,200.0
BASF SE €51.41 €65.00
Security Price Target price
Vapiano €0.40 €1.50
Nanodimension Ltd. ADR €1.74 €1.00
Eastman Kodak €8.24 €10.00

Pros and Cons of these stocks (New Predictions)

Risky Investment
Tell us your opinion to access the 'Wisdom of the Crowds'
Tell us your opinion to access the 'Wisdom of the Crowds'
Tell us your opinion to access the 'Wisdom of the Crowds'

Tops & Flops

Security Price Change(%) (%)
Fortune Brands Home & Security Inc. €65.00 18.180%
Assurant Inc. €101.00 14.770%
KeyCorp €11.00 10.000%
Mohawk Industries Inc. €79.00 8.220%
Advanced Micro Devices Inc. €70.07 7.010%
Security Price Change(%) (%)
Fleetcor Technologies €200.00 -8.260%
Wynn Resorts Ltd €72.86 -5.340%
Avery Dennison €99.00 -5.290%
American International Group Inc. €26.25 -4.150%
Flir Systems Inc. €31.01 -4.000%

Top Indices (Indication)

Security Price % Buy Sell Target price Potential
Dow Jones 27,960
0.680% 5 2 20,500 -26.681%
S&P 500 3,376.3
0.960% 7 3 3,166.5 -6.213%
FTSE 100 6,263.0
1.920% 2 3 7,000.0 11.768%
Nikkei 225 23,170
2.160% 6 2 20,250 -12.603%


Alamos Gold

Start price
Target price
Perf. (%)

Knorr-Bremse AG

Start price
Target price
Perf. (%)

Jumia Technologies AG

Start price
Target price
Perf. (%)

CytoTools AG

Start price
Target price
Perf. (%)

Latest comments

If you get a failed message on your Cash app screen at the time of making any transaction, then, first of all, you need to check that the entered or linked card details are correct. As well as, check your internet connectivity, the receiver’s details, and also confirm the available funds are sufficient to complete this transaction. If you get any of them, then fix it. For more issues, use Cash app customer service.

Have I sent the money to the wrong person? Want a cash app refund? If you are looking for the technical team’s help then you’re needed to seek the technical help of the techies. They’ll guide you with some quick steps and solutions to get the money back on the cash app. 

Clinical Research courses impart knowledge on how Principal Research Companies and their staff can decide whether a study protocol can progress to the next stage of testing or approval. However, a big challenge is to keep volunteers safe in mind which taking this decision. Therefore, the International Conference on Harmonization(ICH)  has developed Good Clinical Practice(GCP) for FDA –regulated studies to ensure the participant's wellbeing through the trial. For that reason, it is covered in clinical research courses.

An Introduction to GCP

GCP could be defined as a standard for the design, conduct, performance, monitoring, auditing recording, analysis, and reporting of clinical trials or studies. It includes 13 core principles that are set in place to ensure safe and ethical research. These principles are self-explanatory and prompt clinical research professionals that the welfare of the trial should be of the utmost importance while conducting clinical research studies. However, these GCP standards are just guidelines for conducting clinical research and are only applicable to FDA regulated research. Also, research is regulated through the FDA if the trial contains a test article, human subjects and does not include non-clinical laboratory studies. Though Non-FDA research projects are not obligated to follow GCP, following it become the best practice of a study. Clinical research courses give you all the details on the standards of GCP.

The importance of GCP

The main aim of GCP is not only to ensure the quality of data but also to ensure subject rights and safety as well. It also holds everyone who is involved in the clinical trial accountable for the happenings in the clinical trial. The various people who are held accountable in a trial include the Principal Investigator (PI), sponsors and the Institutional Board. Those who are involved in a clinical trial should be confident that the benefits of conducting a clinical trial outweigh the risks in a clinical trial. Also, consistency must be maintained as the protocol goes through the four phases of a clinical trial. When the intervention moves along an application towards approval, the relevant data is maintained in a Trial Master File(TMF). The Good Clinical Practice (GCP) plays an important role in ensuring that clinical data is complete. Therefore, GCP is an important part of Clinical Research Courses.

How can GCP be achieved?

There are four different parts in a clinical protocol that help clinical research professionals to achieve GCP. They are glossary, principles, responsibilities, and documentation.  When these parts are done entirely and accurately, these parts define common terms and acronyms, hold research staff accountable and help with the conducting of a proper trial. Each part helps convey that the study is designed to ensure ethical research as well as the safety of the participants. Clinical research courses are the ultimate guide on how to achieve GCP.

To sum up, it is important to keep up-to-date on GCP training as well as ensuring one’s trials stay up to standard. Clinical Research courses can give you a perfect understanding of GCP.

Top News


NOXXON to Present Final Clinical Data From the NOX-A12 / Keytruda® Combination Trial in Colorectal and Pancreatic Cancer at the ESMO Virtual Congress 2020

Regulatory News:

NOXXON Pharma N.V. (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today that its poster

Keysight’s 5G User Equipment Emulation Solutions Selected by Baicells to Validate Performance of Base Stations

Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that helps enterprises, service providers and governments accelerate innovation to connect and secure the world, announced

First Internet Bank Continues SBA Expansion

First Internet Bank announced today that two new Senior Business Development Officers have joined its Small Business Administration (SBA) Lending team. With the additions of Jared Johnson and Ryan

Gold Terra Grants Options

August 12, 2020, Vancouver, B.C. – Gold Terra Resource Corp. (TSX-V: YGT; Frankfurt: TX0; OTC Pink: TRXXF) (“Gold Terra” or the “Company -

Sports Medicine Startup Empericus Teams up With Wolters Kluwer to Transform Athlete Management and Patient Care

Wolters Kluwer, Health today announced that Empericus, an innovative, evidence-based platform for patient care and athlete management, has selected Health Language® to accelerate healthcare data

Advance Auto Parts Moves Auto Repair Software into the Future with Next Generation MotoLogic® Technology Designed to Help Auto Technicians Serve Customers with Accuracy, Speed and Added Value

Advance Auto Parts, Inc. (NYSE: AAP), a leading automotive aftermarket parts provider, has made it even easier for automotive technicians and repair shops to bring added-value to their customers by

Medallia Announces Timing of Second Quarter 2021 Financial Results

Medallia Inc. (NYSE: MDLA), the global leader in experience management, today announced that it will report financial results for the second quarter of fiscal year 2021 on Thursday, September 3

LivaNova to Present Autonomic Regulation Therapy Findings for Heart Failure During European Society of Cardiology Congress 2020

LivaNova PLC (NASDAQ:LIVN) a market-leading medical technology and innovation company, today announced it will present a poster at the European Society of Cardiology (ESC) Congress 2020 on the


Compete in Catch the Monkey ...

... and win a prize!